Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Neuroprotective agent")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4135

  • Page / 166
Export

Selection :

  • and

A review of neuroprotective agentsLEVI, M. S; BRIMBLE, M. A.Current medicinal chemistry. 2004, Vol 11, Num 18, pp 2383-2397, issn 0929-8673, 15 p.Article

Design, synthesis and evaluation of N-(substituted benzothiazol-2-yl)amides as anticonvulsant and neuroprotectiveHASSAN, Mohd zaheen; KHAN, Suroor A; AMIR, Mohd et al.European journal of medicinal chemistry. 2012, Vol 58, pp 206-213, issn 0223-5234, 8 p.Article

Les nouvelles de la neuroprotection - volume IIHEINZLEF, O.La Lettre du neurologue. 2008, Vol 12, Num 8, issn 1276-9339, 15 p., SUPSerial Issue

Ketamin = KetamineDer Anaesthesist (Berlin. Print). 1997, Vol 46, issn 0003-2417, 71 p., SUP1Serial Issue

Triazolbenzo[d]thiazoles: Efficient synthesis and biological evaluation as neuroprotective agentsAVILA, Belem; ROTH, Aaron; STREETS, Heather et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 18, pp 5976-5978, issn 0960-894X, 3 p.Article

Two neuroprotective compounds from mushroom Daldinia concentricaLEE, In-Kyoung; YUN, Bong-Sik; KIM, Young-Ho et al.Journal of microbiology and biotechnology. 2002, Vol 12, Num 4, pp 692-694, issn 1017-7825, 3 p.Article

Xenon measurement in breathing systems : a comparison of ultrasonic and thermal conductivity methodsKING, R; BRETLAND, M; WILKES, A et al.Anaesthesia. 2005, Vol 60, Num 12, pp 1226-1230, issn 0003-2409, 5 p.Article

Cannabinoids as neuroprotective agents in traumatic brain injury : Current status of neuroprotection in traumatic brain injuryBIEGON, Anat.Current pharmaceutical design. 2004, Vol 10, Num 18, pp 2177-2183, issn 1381-6128, 7 p.Article

Sabeluzole stabilizes the neuronal cytoskeletonGEERTS, H; NUYDENS, R; DE JONG, M et al.Neurobiology of aging. 1996, Vol 17, Num 4, pp 573-581, issn 0197-4580Article

Taurine as osmoregulator and neuromodulator in the brainOJA, S. S; SARANSAARI, P.Metabolic brain disease. 1996, Vol 11, Num 2, pp 153-164, issn 0885-7490Conference Paper

Perioperative nimodipine and postoperative analgesiaCASEY, Gerri; NORTCLIFFE, Sally-Ann; SHARPE, Paul et al.Anesthesia and analgesia. 2006, Vol 102, Num 2, pp 504-508, issn 0003-2999, 5 p.Article

Ketamin und Neuroprotektion : Klinischer Ausblick = Ketamine and neuroprotection. A clinical outlookFITZAL, S.Der Anaesthesist (Berlin. Print). 1997, Vol 46, pp S65-S70, issn 0003-2417, SUP1Article

Response to Nimodipine in Ultradian Bipolar Cycling After AmygdalohippocampectomyDE LEON, Ovidio A.Journal of clinical psychopharmacology. 2012, Vol 32, Num 1, pp 146-148, issn 0271-0749, 3 p.Article

Estrogen neuroprotection: the involvement of the Bcl-2 binding protein BNIP2BELCREDITO, Silvia; VEGETO, Elisabetta; BRUSADELLI, Alessia et al.Brain research reviews. 2001, Vol 37, Num 1-3, pp 335-342, issn 0165-0173Conference Paper

Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonistTAGGART, D. P; BROWNE, S. M; WADE, D. T et al.Heart (London 1996). 2003, Vol 89, Num 8, pp 897-900, issn 1355-6037, 4 p.Article

PEDF: A multifaceted neurotrophic factorTOMBRAN-TINK, Joyce; BARNSTABLE, Colin J.Nature reviews. Neuroscience (Print). 2003, Vol 4, Num 8, pp 628-636, issn 1471-003X, 9 p.Article

Neuroprotective effects of infliximab in experimental spinal cord injury. CommentaryKURT, Gökhan; ERGÜN, Ertan; CEMIL, Berker et al.Surgical neurology. 2009, Vol 71, Num 3, pp 332-336, issn 0090-3019, 5 p.Article

Baicalein and wogonin are activators of rat TREK-2 two-pore domain K+ channelKIM, E.-J; KANG, D; HAN, J et al.Acta physiologica (Print). 2011, Vol 202, Num 2, pp 185-192, issn 1748-1708, 8 p.Article

The pharmacokinetics of erythropoietin in the cerebrospinal fluid after intravenous administration of recombinant human erythropoietinXENOCOSTAS, Anargyros; CHEUNG, Wing K; MESSNER, Hans A et al.European journal of clinical pharmacology. 2005, Vol 61, Num 3, pp 189-195, issn 0031-6970, 7 p.Article

Direct protection of inosine on PC12 cells against zinc-induced injuryMING SHI; YOU, Si-Wei; MENG, Jin-Hong et al.Neuroreport (Oxford). 2002, Vol 13, Num 4, pp 477-479, issn 0959-4965Article

Neuroprotective effects of curculigoside against NMDA-induced neuronal excitoxicity in vitroZHEN TIAN; WEI YU; LIU, Hong-Bao et al.Food and chemical toxicology. 2012, Vol 50, Num 11, pp 4010-4015, issn 0278-6915, 6 p.Article

N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal traumaPATEL, Samir P; SULLIVAN, Patrick G; PANDYA, Jignesh D et al.Experimental neurology (Print). 2014, Vol 257, pp 95-105, issn 0014-4886, 11 p.Article

Intense Correlation Between Brain Infarction and Protein-Conjugated AcroleinSAIKI, Ryotaro; NISHIMURA, Kazuhiro; ISHII, Itsuko et al.Stroke (1970). 2009, Vol 40, Num 10, pp 3356-3361, issn 0039-2499, 6 p.Article

Clinical impact of NXY-059 demonstrated in the SAINT I trial : Derivation of number needed to treat for benefit over entire range of functional disabilitySAVER, Jeffrey L.Stroke (1970). 2007, Vol 38, Num 5, pp 1515-1518, issn 0039-2499, 4 p.Article

Is white matter involved in patients entered into typical trials of neuroprotection?HO, Prahlad W; REUTENS, David C; PHAN, Thanh G et al.Stroke (1970). 2005, Vol 36, Num 12, pp 2742-2744, issn 0039-2499, 3 p.Article

  • Page / 166